Unity Biotechnology, Inc. Available-for-sale Securities
Unity Biotechnology, Inc. had Available-for-sale Securities of $169.87 million as of 2018-12-31, per its 10-K filed 2019-03-06.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecurities · last filed 2019-03-06
- 2018-12-31: Available-for-sale Securities $169.87M.
- 2018-09-30: Available-for-sale Securities $155.30M.
- 2018-06-30: Available-for-sale Securities $163.88M.
- 2017-12-31: Available-for-sale Securities $90.04M; Available-for-sale Securities as first filed $84.33M.
| Period end | Available-for-sale Securities | Available-for-sale Securities as first filed |
|---|---|---|
| 2018-12-31 | $169.87M 10-K · filed 2019-03-06 | |
| 2018-09-30 | $155.30M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $163.88M 10-Q · filed 2018-08-09 | |
| 2017-12-31 | $90.04M 10-K · filed 2019-03-06 | $84.33M 10-Q · filed 2018-06-07 |